SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2012 |
Sector | Life Science |
Employees | 50,000 |
Revenue | 54.3B USD (2023) |
AbbVie is a research-based biopharmaceutical company. AbbVie develops and markets advanced therapies that address complex and serious diseases. AbbVie's products are focused on treating conditions such as chronic autoimmune diseases, including rheumatoid arthritis, psoriasis, and Crohn's disease; low testosterone; HIV; endometriosis; thyroid disease; Parkinson's disease; and complications associated with chronic kidney disease and cystic fibrosis, among other health conditions. AbbVie was founded in 2012 and is based in North Chicago, Illinois.
DEAL STATS | # |
---|---|
Overall | 4 of 11 |
Sector (Life Science) | 4 of 11 |
Type (Add-on Acquisition) | 3 of 10 |
State (New Jersey) | 1 of 1 |
Country (United States) | 4 of 9 |
Year (2019) | 1 of 2 |
Size (of disclosed) | 1 of 9 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2016-04-28 |
Stemcentrx
South San Francisco, California, United States Stemcentrx develops therapies that aim to cure and significantly improve survival for cancer patients. The Company was formed in 2008 and is based South San Francisco, California. |
Buy | $5.8B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2019-07-15 |
Mavupharma
Kirkland, Washington, United States Mavupharma is a biopharmaceutical company focused on novel approaches to target the STING (STimulator of INterferon Genes) pathway for the treatment of cancer. Mavupharma was founded in 2016 and is based in Kirkland, Washington. |
Buy | - |